Karen Deborah Chagin - 19 Feb 2026 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Medical Officer
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 19 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 23 Feb 2026, 16:18:52 UTC
Previous filing: 09 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chagin Karen Deborah	Chief Medical Officer	2001 MARKET ST, SUITE 3915 UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	23 Feb 2026	0002070710

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNTX	Stock Option (right to buy)	Award	$0	+290,000		$0.000000	290,000	19 Feb 2026	Common Stock	290,000	$2.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.